Evidence map›Paper›PMID 26108667›Full record

ArticleAmerican journal of physiology. Cell physiology2015

Seeing is believing: NO therapy for glaucoma? Focus on "Role of nitric oxide in murine conventional outflow physiology".

Natasha M Rogers, Jeffrey S Isenberg

Abstract readEditorialComment
In one paragraph

Article in American journal of physiology. Cell physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Role of nitric oxide in murine conventional outflow physiology.American journal of physiology. Cell physiology · 2015
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Natasha M RogersHeart, Lung, Blood, and Vascular Medicine Institute of the University of Pittsburgh, Pittsburgh, Pennsylvania; Renal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and.
Jeffrey S IsenbergHeart, Lung, Blood, and Vascular Medicine Institute of the University of Pittsburgh, Pittsburgh, Pennsylvania; Division of Pulmonary Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania jsi5@pitt.edu.

Funding

Vascular Subphenotypes of Lung DiseaseP01HL103455 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GLADWIN, MARK T · 2011 to 2020
$26.1M
TSP-1 and ROS: CD47 and SIRP-alpha as Mediators of Vascular DysfunctionR01HL112914 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ISENBERG, JEFFREY S, PAGANO, PATRICK J · 2013 to 2016
$1.7M
TSP1-CD47 in Promotion of PAH-Associated Vasoconstriction and Vascular OvergrowthR01HL108954 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ISENBERG, JEFFREY S · 2011 to 2014
$1.4M
NHLBI NIH HHS 1R01 HL-112914-01A1NHLBI NIH HHS P01 HL-103455NHLBI NIH HHS R01 HL-108954
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAqueous HumorFemaleGlaucomaHumansIntraocular PressureMaleNitric OxideNitric Oxide Synthase Type IIINitric OxideNitric Oxide Synthase Type III

Identifiers

PMID26108667
PMCPMC4537933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.